Driehaus Capital Management’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Driehaus Capital Management’s Portfolio OACCW Stock Details OACCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-180,000	Closed	-$128K	–	456
2025 Q4	$128K	Hold	180,000	–	–	﹤0.01%	391
2025 Q3	$157K	Hold	180,000	–	–	﹤0.01%	420
2025 Q2	$151K	Hold	180,000	–	–	﹤0.01%	406
2025 Q1	$122K	Buy	+180,000	New	+$137K	﹤0.01%	386

Other funds holding OACCW

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return

BGIM

Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Driehaus Capital Management's OACCW Position: Q1 2026 in Review

Driehaus Capital Management sold out of Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) in Q1 2026, closing a stake of 180,000 shares — an estimated $128K sold.

Driehaus Capital Management first reported a position in OACCW in Q1 2025 and held it in 4 quarters. The position peaked at $157K in Q3 2025. 26 funds tracked by Wall St. Rank hold OACCW as of Q1 2026.

Driehaus Capital Management reported no remaining Oaktree Acquisition Corp III Life Sciences Warrant position as of Q1 2026 after selling out during the quarter.
Driehaus Capital Management sold 180,000 Oaktree Acquisition Corp III Life Sciences Warrant shares in Q1 2026, an estimated $128K.
Driehaus Capital Management first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q1 2025 and held it in 4 quarters.
Driehaus Capital Management's Oaktree Acquisition Corp III Life Sciences Warrant position peaked at $157K in Q3 2025.
26 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.